Figure 2.
Strong reactivity with the LRP-56 monoclonal antibody of breast cancer tumor cells,
as opposed to the inert stromal background. Streptavidin-biotin-peroxidase staining.
Magnification ×400.
Schneider et al. Breast Cancer Res 2001 3:183 doi:10.1186/bcr293